NGNE (Neurogene) Change In Receivables : $0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Neurogene Change In Receivables?

Neurogene's change in receivables for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Neurogene's Accounts Receivable stayed the same from Sep. 2024 to Dec. 2024 .

Neurogene's change in receivables for the fiscal year that ended in Dec. 2024 was $0.00 Mil. It means Neurogene's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

Neurogene's Accounts Receivable for the quarter that ended in Dec. 2024 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Neurogene's liquidation value for the three months ended in Dec. 2024 was $287.05 Mil.

Neurogene Change In Receivables Historical Data

The historical data trend for Neurogene's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Change In Receivables Chart

Neurogene Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Neurogene Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial						-	-	-	-	-

Neurogene Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Neurogene (NAS:NGNE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Neurogene's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Neurogene's accounts receivable are only considered to be worth 75% of book value:

Neurogene's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	312.405	-	25.355	+	0.75 * 0	+	0.5 * 0
=	287.05

Neurogene Change In Receivables Related Terms

Thank you for viewing the detailed overview of Neurogene's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurogene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

535 W 24th Street, 5th Floor, New York, NY, USA, 10011

Website

https://www.neurogene.com

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.